So, we asked our leadership, ‘What health care trend or technology are you most excited to follow in 2020 and why?’
Read their responses to learn what is on the top of their mind as we end 2019 and look forward to 2020.
- In 2020, I’ll be closely watching the continued evolution of the care setting. Telemedicine, the rise in retail clinics, and community-based care models are moving care into non-traditional settings, including the home. I think we will see more development in this area in the new year, particularly as the value-based and regulatory landscapes continues to develop. – Kathryn Heffernan, Product Manager, Digital Solutions
Consumerism in Health Care
- Heading into 2020, I am excited to see the continued consumerization of health care. From patient apps that help the patient take control of their medical records to the continued integration of patient-generated data via Apple Health Kit and other means, the time is ripe for patients to take control of their care with digital tools and begin to expect the quality of digital experiences found in other industries. – Jackie Gelzheiser, Director, Marketing and Communications
- There are two trends that come to mind as we look to 2020. First, understanding that patients are becoming more like consumers, being charge of their health, and health care providers being much more customer-centric. Second, biosensing technology – wearables that track sickness and not just fitness levels. I believe that health care is still lagging compared to the other sectors and it is great to see the market demanding more, in terms of innovation as well as a more customer-centric approach to providing care. – Ketaki Desai, Director, Translational Sciences
Health Care Data Security
- I’m really excited to see how the tidal wave of support behind HL7 FHIR from “Big Tech”, “Big EHRs”, and Government Agencies will drive meaningful value for our patients in 2020. My interest in FHIR goes back to 2014 and I’ve been a strong champion ever since. In 2019, there was a pretty dramatic shift from implementing FHIR to exploiting FHIR to drive value. I can’t wait to see what sort of innovations come as a result. – Brian Kolowitz, Director Technology – AI, NLP, API Developer Experience (DX)
- In my area of focus, translational life sciences, I am looking forward to seeing what 2020 brings for the integration of real-world data and evidence into the drug discovery and development process. The opportunity to accelerate the discovery and reduce the development cost of novel therapies is tremendous, but data silos remain and a growing number of players in this space will increasingly be asked to demonstrate the value of their services and solutions. Doing all of this while ensuring patient privacy and compliance with all relevant regulatory frameworks (e.g. HIPAA) will mean companies in this space will have a long ‘To-do’ list for 2020, which should make for interesting developments to monitor over the course of 2020. – Matthias Kleinz, Vice President, Translational Sciences
Health Care Innovation
- I’m interested in keeping a close eye on two specific trends in health care. First, I’m curious to see if 2020 will be the year we start to see value-based care accelerate providers to take on more risk contracts. And second, I’m curious to see how the political landscape impacts opportunities for innovation and investment in health care. - Mike Duddy, Director, Product Management
Machine Learning in Health Care
- While not a new thing, I am looking forward to following the progression of precision medicine through better use of AI and Machine Learning. Following the course of my mother in the last year or so of her life, suffering from breast and lung cancer, I am convinced that more personalized care would have not only extended her life, but made that portion of her life more livable. – Tony Parfitt, Senior Director, Engineering
UPMC Enterprises announces $1 billion commitment to life sciences investments
The Translational Sciences team at UPMC Enterprises will be investing $1 billion by 2024 to develop new drugs, diagnostics, and devices.
Meet the Executive: Wendy Zellner, Vice President of Public Relations at UPMC
At UPMC, Zellner helps to oversee UPMC’s roughly 15-person media group (covering UPMC and Pitt Schools of the Health Sciences), and personally works with UPMC’s Enterprises, International, Information Services, and Quality divisions to identify and tell the organizations’ best stories to the media.